EP0711341A4 - Receptor function assays - Google Patents

Receptor function assays

Info

Publication number
EP0711341A4
EP0711341A4 EP94924067A EP94924067A EP0711341A4 EP 0711341 A4 EP0711341 A4 EP 0711341A4 EP 94924067 A EP94924067 A EP 94924067A EP 94924067 A EP94924067 A EP 94924067A EP 0711341 A4 EP0711341 A4 EP 0711341A4
Authority
EP
European Patent Office
Prior art keywords
receptor function
function assays
assays
receptor
function
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP94924067A
Other languages
German (de)
French (fr)
Other versions
EP0711341A1 (en
Inventor
Neill A Giese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COR Therapeutics Inc
Original Assignee
COR Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COR Therapeutics Inc filed Critical COR Therapeutics Inc
Publication of EP0711341A1 publication Critical patent/EP0711341A1/en
Publication of EP0711341A4 publication Critical patent/EP0711341A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205—Phosphotransferases in general
    • G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
EP94924067A 1993-07-29 1994-07-29 Receptor function assays Withdrawn EP0711341A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US99850 1987-09-22
US9985093A 1993-07-29 1993-07-29
PCT/US1994/008571 WO1995004136A1 (en) 1993-07-29 1994-07-29 Receptor function assays

Publications (2)

Publication Number Publication Date
EP0711341A1 EP0711341A1 (en) 1996-05-15
EP0711341A4 true EP0711341A4 (en) 2001-12-19

Family

ID=22276905

Family Applications (1)

Application Number Title Priority Date Filing Date
EP94924067A Withdrawn EP0711341A4 (en) 1993-07-29 1994-07-29 Receptor function assays

Country Status (6)

Country Link
EP (1) EP0711341A4 (en)
JP (1) JPH09501767A (en)
AU (1) AU7408094A (en)
CA (1) CA2166871A1 (en)
SG (1) SG63596A1 (en)
WO (1) WO1995004136A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19741716A1 (en) * 1997-09-22 1999-03-25 Hoechst Ag Recognition system
US6406869B1 (en) 1999-10-22 2002-06-18 Pharmacopeia, Inc. Fluorescent capture assay for kinase activity employing anti-phosphotyrosine antibodies as capture and detection agents
DE10323081A1 (en) * 2003-05-22 2004-12-16 Aventis Pharma Deutschland Gmbh Use of a polypeptide
JP2008544285A (en) * 2005-06-24 2008-12-04 ベックマン コールター， インコーポレイテッド Phosphorylated protein immunoassay
US20090170925A1 (en) 2007-10-29 2009-07-02 Eisai R&D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
NZ599460A (en) * 2009-10-20 2014-07-25 Nestec Sa Proximity-mediated assays for detecting oncogenic fusion proteins

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013870A1 (en) * 1991-01-31 1992-08-20 The Regents Of The University Of California Human platelet-derived growth factor receptors
WO1995014930A1 (en) * 1993-11-23 1995-06-01 Genentech, Inc. Kinase receptor activation assay
EP1000617A2 (en) * 1994-01-07 2000-05-17 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992013870A1 (en) * 1991-01-31 1992-08-20 The Regents Of The University Of California Human platelet-derived growth factor receptors
WO1995014930A1 (en) * 1993-11-23 1995-06-01 Genentech, Inc. Kinase receptor activation assay
EP1000617A2 (en) * 1994-01-07 2000-05-17 Sugen, Inc. Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9504136A1 *

Also Published As

Publication number Publication date
SG63596A1 (en) 1999-03-30
WO1995004136A1 (en) 1995-02-09
EP0711341A1 (en) 1996-05-15
CA2166871A1 (en) 1995-02-09
JPH09501767A (en) 1997-02-18
AU7408094A (en) 1995-02-28

Similar Documents

Publication Publication Date Title
EP0705426A4 (en) Antigen-specific one-step assays
GB9014903D0 (en) Assays
PL314120A1 (en) B-adrenergic antagonists
GB9412166D0 (en) Retargetting antibodies
GB9517098D0 (en) Receptor
GB9614351D0 (en) Assay
SG63596A1 (en) Receptor function assays
GB9715522D0 (en) Assays
EP0719345A4 (en) Reagent
GB9606887D0 (en) Assay
GB9311854D0 (en) Trh receptor action
GB9107983D0 (en) Assays
AU6161894A (en) Cholecystokinin antagonists
GB9318105D0 (en) Receptor action
GB9308544D0 (en) Assay
GB9312638D0 (en) Assay
GB9425502D0 (en) Novel receptor
GB9304975D0 (en) Capture assays
GB9307732D0 (en) Assay
GB9307659D0 (en) Assay
GB9315622D0 (en) Assay
GB9424925D0 (en) Immunoassay
GB9416553D0 (en) Novel receptor proteins
GB9015353D0 (en) Assays
GB9320508D0 (en) Antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960115

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20011102

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7C 12N 9/12 A, 7G 01N 33/53 B, 7G 01N 33/543 B, 7G 01N 33/545 B, 7G 01N 33/573 B, 7G 01N 33/566 B

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040202